d(GC) - Association of Biotechnology and Pharmacy
d(GC) - Association of Biotechnology and Pharmacy
d(GC) - Association of Biotechnology and Pharmacy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 6 (2) 119-144 April 2012, ISSN 0973-8916 (Print), 2230-7303 (Online)<br />
Table 1. Cumulative burden (%) <strong>of</strong> cancer deaths <strong>and</strong> incidence, <strong>and</strong> likelihood <strong>of</strong> survival by age group compared for less <strong>and</strong> more<br />
developed countries. Raw data taken from IARC (16) <strong>and</strong> comparisons were performed using the GLOBOCAN Online Analysis - Age-Specific<br />
Tables tools, using Population as Less Developed, More Developed or Panama; Sex as Both Sexes; Data Type as Incidence or Mortality; <strong>and</strong><br />
Statistic as Numbers. ‘Deaths’ <strong>and</strong> ‘Incidence’ expressed as the cumulative percentage <strong>of</strong> deaths (or incidences) occurring due to cancer in<br />
defined age groups. ‘Crude likelihood <strong>of</strong> survival’ calculated as [1-total number <strong>of</strong> deaths/total number <strong>of</strong> incidences]. Relative likelihood <strong>of</strong><br />
survival calculated as [Crude likelihood <strong>of</strong> survival for Less developed countries or Panama/Crude likelihood <strong>of</strong> survival for More developed<br />
countries].<br />
Deaths Incidence Crude likelihood Relative likelihood<br />
<strong>of</strong> survival <strong>of</strong> survival<br />
Age Less More Less More Less More Less<br />
developed developed Panama developed developed Panama developed developed Panama developed Panama<br />
0-14 1.9 0.2 1.9 2.1 0.5 2.9 0.36 0.80 0.53 0.45 0.66<br />
15-39 9.4 1.8 8.3 12.1 4.5 12.0 0.47 0.79 0.52 0.59 0.66<br />
40-44 14.1 3.2 11.2 18.3 7.3 16.2 0.46 0.72 0.52 0.64 0.72<br />
45-49 20.4 6.3 15.2 26.1 11.9 21.0 0.42 0.66 0.42 0.64 0.64<br />
50-54 29.5 11.6 20.8 36.5 18.9 27.1 0.38 0.60 0.37 0.63 0.62<br />
55-59 40.8 19.9 29.2 48.7 28.8 36.0 0.34 0.56 0.35 0.61 0.63<br />
60-64 52.0 29.7 38.7 60.1 40.3 46.1 0.30 0.55 0.35 0.55 0.64<br />
65-69 64.3 42.2 50.2 71.8 53.5 58.3 0.25 0.51 0.35 0.49 0.69<br />
70-74 77.6 57.2 63.3 83.3 68.2 71.5 0.18 0.46 0.31 0.39 0.67<br />
75+ 100.0 100.0 100.0 100.0 100.0 100.0 0.05 0.29 0.11 0.17 0.38<br />
Rebecca E. Smith <strong>and</strong> Juan Miguel Pascale<br />
122